Thermo Fisher Scientific sponsors lab facility to support emerging biotechs
.png)
To assist with the growth of the biotechnology industry and support newly emerging biotech companies, Thermo Fisher Scientific have made the move to be a founding sponsor of Momentum Labs in Alachua, FL, USA.
Momentum Labs is a space that can be used by start-up biotechs, for laboratory space or office space to help facilitate their work and progress in injecting new therapies into the market, a hurdle that would otherwise slow or even prevent such companies from doing so. The laboratory is managed by Concept Companies, a real estate development firm in the area.
“From a regional and state perspective, Momentum Labs provides critical infrastructure and business development resources to support the growth of life sciences in Florida, giving the ecosystem the opportunity to retain companies rather than losing them to other communities,” explained Abhinav Akhoury, vice president, corporate accounts, Thermo Fisher Scientific. “Through our sponsorship, Momentum Labs has the ability to provide the latest innovative technologies to high-growth life science companies that are developing tomorrow’s life-changing medicines.”
This region of Florida is a hub of biotech activity, with over 100 life sciences companies in the area, making a huge impact on the local economy and providing 1,200 jobs in the state. However, despite this established market, there is little room for growth and the micro industry here is dominated by larger biotech companies. This means it is increasingly difficult for small companies who are just starting out, with good ideas, to develop in this space. Momentum Labs will provide this initial space for the growing companies, giving them a solid grounding to scale up from, without having to abandon the market in North central Florida.
Incubator programmes such as these are shown to support the survival of companies by increasing the likelihood of their continuance by 87% after five years. After this, the companies are 84% more likely to stay in the hubs where they received their support. With Thermo Fisher’s support, more companies will be able to take advantage of this scheme and have viable access to much needed equipment and infrastructure, and solidify their debuts into the industry as valued players.
“It’s challenging for growing companies to stay ahead of their space needs,” commented Brian Crawford, chief executive officer at Concept Companies. “Not only is there a large expense for all the equipment needed, but there are also often extraordinary lead times associated with the acquisition and installation. Partnering with Thermo Fisher Scientific gives us the ability to offer the latest innovative instrumentation and equipment to our members allowing them to leverage their capital for growth.”
“By developing a purpose-built facility for emerging science in the Gainesville community, Momentum Labs is providing critical lab space, access to quality equipment, instrumentation and services, and tailored business development support these companies need for continued exponential growth,” explained Kyla Frye, director of science and technology ecosystems and lead for Momentum Labs. “This ultimately helps us retain growing life sciences companies and their talent in the region while giving them the vital resources to advance their therapies from research to the clinic.”

Related News
-
News Anima Biotech brings mRNA biology modulators to AbbVie against oncology and immunology targets
A USD $42 million collaboration between AbbVie and Anima Biotech aims to leverage the latter’s mRNA Lightning technology platform to enhance therapeutic development programs in oncology and immunology. -
News Alzheimer's drug Leqembi receives go ahead from the FDA to be used in patients
Eisai achieves FDA approval for it's Alzheimer's disease drug Leqembi, after rigorous testing in clinical trials show it reduces the size of characteristic plaques in the brains of patients. -
News CordenPharma signs billion dollar agreement to manufacture new peptide
CordenPharma, the CDMO specialising in APIs, lipid excipients, and drug products, signs a new billion dollar contract to expand its manufacturing capabilities. -
News Algorithm accelerated: machine-learning may reduce drug formulation development times
Machine-learning models demonstrate the potential to accelerate drug formulation discovery and development for long-acting injectables. -
News The Biggest Drug Approvals of 2022
A carefully curated list of the most notable drug approvals of the past year, covering neurology, oncology, and COVID-19, as well as a look at the most promising drugs up for review in 2023. -
News Abortion pills can now be sold in retail pharmacies according to the US FDA
In the US, retail pharmacies will be allowed to sell abortion pills for the first time, after latest approval is granted by the FDA. -
News Moderna to buy OriCiro Genomics in USD $85 million deal
Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio. -
News New year, new prices: at least 350 drugs in USA to see price increases in January
Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance